Practice Enhancement Programs

Practice Enhancement Programs (PEP) are important projects that combine the elements of a clinical trial as well as continuing professional development (CPD).

The purpose of Practice Enhancement Programs is to identify patients with cardiovascular disease who are not optimally controlled and to provide treatment in accordance with Current Canadian guidelines.

Select a CHRC registry below:

	DYSIS - Epidemiological study sharing same protocol in various countries in Europe and Canada to estimate the prevalence of types of lipid abnormalities, and associated risks and relationship between the persistent lipid abnormalities and local known prevalence of CV morbidity and mortality.
	PRIMULA - Practice Enhancement Program
	GUIDANC - Guideline based undertaking to improve dyslipidemia management in Canada - Quality Enhancement Research Initiative in the Dyslipidemia Management Strategy Involving Monotherapy and in Combination therapy with Statin in Hugh Risk Patients who have not achieved recommended LDL Targets
	CANRACE - Practice Enhancement Program
	Pulmonary Arterial Hypertension Quality Enhancement Research Initiative (PAH QuERI) represents an innovative integration of guidelines and clinical care delivery aimed to identify and implement evidence based practices in routine health care setting.
	QuERI - Scleroderma Pulmonary Hypertension Quality Enhancement Research Initiative
	Multi-Center, Open Label Observational Quality Enhancement Research Initiative (QERI) in the glycemic control management involving patients with type 2 diabetes (DM) observational study conducted over a 12 month treatment period (4 Visits) with 300-400 physicians across Canada. n

			ONLINE PRESENTATIONS > click here to view the Canadian Heart Research Centre's library of online presentations.
				SLIDE KIT DOWNLOADS > click here to view the Canadian Heart Research Centre's library of slide kits.
					ACS GUIDELINES > click here to view the Canadian Heart Research Centre's ACS Guidelines
					AWARE MD > click here to view the Canadian Heart Research Centre's AwareMD's Cardiovascular Therapeutic Recommendation
					CHRC THERAPEUTIC RECOMMENDATIONS: DYSLIPIDEMIA IN HIGH-RISK PATIENTS This section of chrc.net is currently undergoing maintenace.

CHRC Therapeutic Recommendations

Welcome to the Canadian Heart Research Centre Therapeutic Recommendations section of our website. For more details, please choose your topic of interest below and click on the corresponding icon to download PDF files relating to that topic:

+ ACUTE CORONARY SYNDROMES
click here to download the CJC PUBLICATION
click here to download the graphs
+ DYSLIPIDEMIA
(COMING SOON)
+ HYPERTENSION
(COMING SOON)
+ ATRIAL FIBRILLATION
(COMING SOON)
+ CONGESTIVE HEART FAILURE
(COMING SOON)